Today, Pascal Metrics is pleased to announce groundbreaking results and a new way of doing patient safety called virtual patient safety (“VPS”), a first-ever capability for global healthcare that enables health systems to measure and manage “All-cause harm All the time for All patients.”

And it comes at no better time. COVID-19 has increased the risk of physical presence and consequently the value of “the virtual,” resulting in demand for remote patient monitoring. COVID-19 has also elevated the patient safety priority, resulting in demand for remote patient safety monitoring.

With VPS, Pascal delivers that, and much more. For over a decade Pascal’s multidisciplinary expert team of clinicians, scientists, informaticists, technologists and others have developed and refined the basic building blocks through painstaking iterative improvement — week after week, month after month, and year after year.

The result? A clinically effective and operationally efficient way to identify and reduce safety vulnerabilities and quality variation that we now can deliver through a comprehensive fully turnkey 24/7 VPS solution.

More important than the capability result are the client results. Today Pascal is grateful to announce that this approach we pioneered and commercialized in our Community Collaborative of leading hospitals and health systems now leads the industry with truly groundbreaking outcomes:

Clients are not only identifying 10x-30x the level of harm as compared to traditional methods – i.e. voluntary event reporting and claims-based approaches – but also reducing that greater level of harm by 60%-80%.

Because COVID-19 placing caregivers under more pressure than ever before, who are often less resourced, the case has never been stronger for conducting systematic safety surveillance of “All-cause harm All the time for All patients.”

If you or a loved one were a patient in the hospital, would you prefer this approach protecting your safety, or the traditional “see something, say something” method that most hospitals still rely upon?

Indeed, this is a new era. We expect that the field will focus on the following imperatives going forward:

  • “First, find the harm” – as Dr. David Stockwell, Pascal’s CMO often says
  • Measure with EHR-based clinically validated adverse event outcomes (“AE Outcomes”)
  • Manage intervention and improvement with AE Outcomes
  • If high reliability is the goal, rely on reliable AE Outcomes instead of unreliable reporting
  • Set board and program safety goals driven by your own delivery system’s patient harm data versus national/other calls to action unreflective of your own safety outcomes
  • When it comes to safety, clinical analytics enterprise-wide should rely first on AE Outcomes, supplemented by event reporting, claims, and other data

Thanks to our clients, our team, a lot of hard work, good fortune, disciplined innovation, and serendipitous discovery, Pascal successfully commercialized this solution. But the real work of reducing harm is done by our health system partners. Stay tuned for more on these leaders in the weeks and months ahead.

Those bold, courageous, and indefatigable leaders at our early adopting clients gave us a chance to show what we could enable, and painstakingly and meticulously we iterated our informatics, workflow, and use of this new timely safety data stream over and over again.

Doing so in live clinical operational environments meant that we necessarily and properly had to be conservative, demanding that we innovate incrementally and with painstaking attention to safety.

It worked, and it’s working.

In a word, this new era for patient safety will be about outcomes. It’s about time, as every day pervasive injury and death due to preventable harm underscore the clinical, financial, and – most importantly – moral imperatives to do something about it.

And as we do, patients will be confident that their care will be safer and more reliable as their caregivers now have the capability, as we say at Pascal, to measure and manage “All-cause harm All the time for All patients.”

The journey continues.